tetano
Editor, Senior Moderator
J Cardiol Cases. 2010 Aug 6;2(2):e106-e110. doi: 10.1016/j.jccase.2010.05.004. eCollection 2010 Oct.
[h=1]A case of fulminant myocarditis associated with novel N1H1 influenza successfully treated by percutaneous cardiopulmonary support system.[/h] Morimoto R[SUP]1[/SUP], Sone T[SUP]1[/SUP], Tsuboi H[SUP]1[/SUP], Mukawa H[SUP]1[/SUP], Morishima I[SUP]1[/SUP], Uesugi M[SUP]1[/SUP], Sasaki H[SUP]1[/SUP], Niwa T[SUP]1[/SUP], Izumi Y[SUP]1[/SUP], Yamamoto T[SUP]1[/SUP], Ichihashi K[SUP]1[/SUP], Kanzaki Y[SUP]1[/SUP], Nagai H[SUP]1[/SUP], Iwata Y[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We report a case of fulminant myocarditis associated with N1H1 influenza virus infection. N1H1 was confirmed by a polymerase chain reaction assay and she was treated with oseltamivir phosphate. She was admitted to the hospital because of respiratory distress, however, echocardiography revealed severely depressed wall motion followed by refractory ventricular fibrillation. Extracorporeal circulation by emergent percutaneous cardiopulmonary support system was required to maintain hemodynamic stability. Cardiac function was spontaneously and gradually restored within a week. Findings from biopsy samples taken on day 1 and day 23 were consistent with acute myocarditis.
[h=4]KEYWORDS:[/h] Fulminant myocarditis; Novel N1H1 influenza; Percutaneous cardiopulmonary support
PMID: 30524598 PMCID: PMC6265007 DOI: 10.1016/j.jccase.2010.05.004
[h=1]A case of fulminant myocarditis associated with novel N1H1 influenza successfully treated by percutaneous cardiopulmonary support system.[/h] Morimoto R[SUP]1[/SUP], Sone T[SUP]1[/SUP], Tsuboi H[SUP]1[/SUP], Mukawa H[SUP]1[/SUP], Morishima I[SUP]1[/SUP], Uesugi M[SUP]1[/SUP], Sasaki H[SUP]1[/SUP], Niwa T[SUP]1[/SUP], Izumi Y[SUP]1[/SUP], Yamamoto T[SUP]1[/SUP], Ichihashi K[SUP]1[/SUP], Kanzaki Y[SUP]1[/SUP], Nagai H[SUP]1[/SUP], Iwata Y[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We report a case of fulminant myocarditis associated with N1H1 influenza virus infection. N1H1 was confirmed by a polymerase chain reaction assay and she was treated with oseltamivir phosphate. She was admitted to the hospital because of respiratory distress, however, echocardiography revealed severely depressed wall motion followed by refractory ventricular fibrillation. Extracorporeal circulation by emergent percutaneous cardiopulmonary support system was required to maintain hemodynamic stability. Cardiac function was spontaneously and gradually restored within a week. Findings from biopsy samples taken on day 1 and day 23 were consistent with acute myocarditis.
[h=4]KEYWORDS:[/h] Fulminant myocarditis; Novel N1H1 influenza; Percutaneous cardiopulmonary support
PMID: 30524598 PMCID: PMC6265007 DOI: 10.1016/j.jccase.2010.05.004